Chemours has placed its President and CEO Mark Newman, Senior Vice President and CFO Jonathan Lock, and Vice President and Controller Camela Wisel on administrative leave pending an internal review. This review, assisted by independent counsel, is examining the company's ethics hotline processes, working capital management practices, non-GAAP metrics, and related disclosures. The company is evaluating potential material weaknesses in its internal control over financial reporting as of December 31, 2023, particularly concerning senior management's 'tone at the top' and information and communication controls.